Status:
COMPLETED
Exercise Oscillatory Breathing and Sildenafil in Heart Failure
Lead Sponsor:
University of Milan
Conditions:
Heart Failure
Eligibility:
MALE
30-80 years
Phase:
PHASE2
Brief Summary
Exercise oscillatory breathing (EOB) is a ventilatory abnormality that occurs in approximately 20% of heart failure (HF) patients and carries a very unfavourable prognosis. Pathophysiology seems quit...
Eligibility Criteria
Inclusion
- consent to participate in the study after detailed information about benefits and risks
- negative exercise stress test prior to study initiation
- forced expiratory volume in 1 sec/forced vital capacity ratio \>70%;
- LVEF \< 45%.
Exclusion
- inability to complete a maximal exercise test
- resting systolic blood pressure \> 140 or \<110 mmHg
- therapy with nitrate preparations
- history of sildenafil intolerance
- significant lung or valvular diseases
- neuromuscular disorders or peripheral vascular disease
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT01185925
Start Date
April 1 2008
End Date
June 1 2010
Last Update
August 5 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.